Factory 99% Enzalutamide Powder CAS 915087-33-1 Antineoplastic Enzalutamide

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A537
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Enzalutamide
• CAS: 915087-33-1
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Antineoplastic
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Enzalutamide
Appearance	White Powder
CAS NO.	915087-33-1
MF	C24H30N6O4S
Storage	Keep in a cool, dry, dark location

 

Enzalutamide is a synthetic chemical compound primarily used in the treatment of prostate cancer. It belongs to a class of medications known as androgen receptor inhibitors.

 

1. Prostate Cancer Treatment: Enzalutamide is prescribed for men with advanced prostate cancer that has spread beyond the prostate gland and is resistant to other therapies.
2. Androgen Receptor Blockade: It effectively blocks the function of androgen receptors in the body, thereby preventing testosterone and other androgens from stimulating cancer cell growth.
3. Improving Survival Rates: Clinical studies have shown that Enzalutamide can significantly extend survival and improve the quality of life for patients with metastatic prostate cancer.

1. Inhibiting Androgen Binding: By binding to androgen receptors, Enzalutamide prevents testosterone and dihydrotestosterone (DHT) from attaching to these receptors, thereby inhibiting their activation and signaling.
2. Disrupting Receptor Function: Enzalutamide not only blocks androgen binding but also disrupts the normal function of androgen receptors, leading to the inhibition of cancer cell proliferation and survival.
3. Reducing Cancer Cell Growth: By inhibiting the androgen receptor signaling pathway, Enzalutamide effectively reduces the growth and spread of prostate cancer cells, providing therapeutic benefits to patients.